ResMed (NYSE:RMD) received an updated price target from RBC Capital Markets following the disclosure of its second-quarter ...
In summary, RBC Capital finds Roper's valuation attractive at current levels, despite the market's general inclination ...
Lower corporate costs also enabled the company to beat profit estimates, said RBC Capital Markets analyst Biraj Borkhataria.
Chevron's downstream business lost $248 million in the fourth quarter of 2024, compared with a profit of $1.15 billion in the ...
“Or a bowling alley, or a bar, or all that other crap. You’ll lose your money.” Instead, O’Leary believes a person could ...